These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 697472)

  • 1. [Aldosteronism after hypokalemia in diuretic therapy of systemic arterial hypertension].
    Sánchez Torres G; Posadas C; Olvera S; Serrano P
    Arch Inst Cardiol Mex; 1978; 48(4):853-70. PubMed ID: 697472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraerythrocytic potassium and diuretic therapy].
    Otto GL; de Carvalho JG; Laffitte A; Baroni G
    Arq Bras Cardiol; 1989 Feb; 52(2):91-3. PubMed ID: 2596994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic-induced hypokalemia and altered renal function.
    Carney SL; Morgan TO
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F; Belogi M; Ansuini R; Campolucci G
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
    Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
    Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of the QT interval in primary aldosteronism.
    Matsumura K; Fujii K; Kansui Y; Arima H; Iida M
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):66-9. PubMed ID: 15730437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium and diuretic-induced ventricular arrhythmias in ambulatory hypertensive patients.
    Caralis PV; Materson BJ; Perez-Stable E
    Miner Electrolyte Metab; 1984; 10(3):148-54. PubMed ID: 6727801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium loss associated with hydrochlorothiazide versus chlorthalidone.
    Sumiye L; Vivian AS; Frisof KB; Podany EC
    Clin Ther; 1981; 4(4):308-20. PubMed ID: 7332917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.
    Griffing GT; Melby JC
    Metabolism; 1989 Apr; 38(4):353-6. PubMed ID: 2725277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
    Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
    Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A beta blockader-diuretic combination in long-term anti-hypertensive therapy. Undesirable effects on blood potassium].
    Severin E; Mladovan G
    Minerva Cardioangiol; 1985 Oct; 33(10):635-7. PubMed ID: 2867493
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
    Rossi AG
    Clin Ther; 1981; 3(6):441-9. PubMed ID: 7260990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists and thiazide diuretics in the treatment of hypertension.
    Ferrara LA; Pasanisi F; Marotta T; Rubba P; Mancini M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S136-7. PubMed ID: 2455115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.